170 related articles for article (PubMed ID: 25522763)
1. A novel compound, NK150460, exhibits selective antitumor activity against breast cancer cell lines through activation of aryl hydrocarbon receptor.
Fukasawa K; Kagaya S; Maruyama S; Kuroiwa S; Masuda K; Kameyama Y; Satoh Y; Akatsu Y; Tomura A; Nishikawa K; Horie S; Ichikawa Y
Mol Cancer Ther; 2015 Feb; 14(2):343-54. PubMed ID: 25522763
[TBL] [Abstract][Full Text] [Related]
2. Aryl hydrocarbon receptor activation of an antitumor aminoflavone: basis of selective toxicity for MCF-7 breast tumor cells.
Loaiza-Pérez AI; Kenney S; Boswell J; Hollingshead M; Alley MC; Hose C; Ciolino HP; Yeh GC; Trepel JB; Vistica DT; Sausville EA
Mol Cancer Ther; 2004 Jun; 3(6):715-25. PubMed ID: 15210858
[TBL] [Abstract][Full Text] [Related]
3. The aryl hydrocarbon receptor (AHR)/AHR nuclear translocator (ARNT) heterodimer interacts with naturally occurring estrogen response elements.
Klinge CM; Bowers JL; Kulakosky PC; Kamboj KK; Swanson HI
Mol Cell Endocrinol; 1999 Nov; 157(1-2):105-19. PubMed ID: 10619402
[TBL] [Abstract][Full Text] [Related]
4. Estrogen receptor α and aryl hydrocarbon receptor independent growth inhibitory effects of aminoflavone in breast cancer cells.
Brinkman AM; Wu J; Ersland K; Xu W
BMC Cancer; 2014 May; 14():344. PubMed ID: 24885022
[TBL] [Abstract][Full Text] [Related]
5. Estrogen receptor subtype- and promoter-specific modulation of aryl hydrocarbon receptor-dependent transcription.
Wihlén B; Ahmed S; Inzunza J; Matthews J
Mol Cancer Res; 2009 Jun; 7(6):977-86. PubMed ID: 19470599
[TBL] [Abstract][Full Text] [Related]
6. Expression of CYP1A1 and CYP1B1 depends on cell-specific factors in human breast cancer cell lines: role of estrogen receptor status.
Angus WG; Larsen MC; Jefcoate CR
Carcinogenesis; 1999 Jun; 20(6):947-55. PubMed ID: 10357772
[TBL] [Abstract][Full Text] [Related]
7. A Molecular Mechanism To Switch the Aryl Hydrocarbon Receptor from a Transcription Factor to an E3 Ubiquitin Ligase.
Luecke-Johansson S; Gralla M; Rundqvist H; Ho JC; Johnson RS; Gradin K; Poellinger L
Mol Cell Biol; 2017 Jul; 37(13):. PubMed ID: 28416634
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms of inhibitory aryl hydrocarbon receptor-estrogen receptor crosstalk in human breast cancer cells.
Safe S; Wormke M; Samudio I
J Mammary Gland Biol Neoplasia; 2000 Jul; 5(3):295-306. PubMed ID: 14973392
[TBL] [Abstract][Full Text] [Related]
9. Aryl hydrocarbon receptor and aryl hydrocarbon nuclear translocator expression in human and rat placentas and transcription activity in human trophoblast cultures.
Stejskalova L; Vecerova L; Peréz LM; Vrzal R; Dvorak Z; Nachtigal P; Pavek P
Toxicol Sci; 2011 Sep; 123(1):26-36. PubMed ID: 21666223
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of aryl hydrocarbon receptor-dependent transcription by resveratrol or kaempferol is independent of estrogen receptor α expression in human breast cancer cells.
Macpherson L; Matthews J
Cancer Lett; 2010 Dec; 299(2):119-29. PubMed ID: 20846786
[TBL] [Abstract][Full Text] [Related]
11. Estrogen and aryl hydrocarbon receptor expression and crosstalk in human Ishikawa endometrial cancer cells.
Wormke M; Castro-Rivera E; Chen I; Safe S
J Steroid Biochem Mol Biol; 2000 Apr; 72(5):197-207. PubMed ID: 10822009
[TBL] [Abstract][Full Text] [Related]
12. Differential expression of CYP1A1 and CYP1B1 in human breast epithelial cells and breast tumor cells.
Spink DC; Spink BC; Cao JQ; DePasquale JA; Pentecost BT; Fasco MJ; Li Y; Sutter TR
Carcinogenesis; 1998 Feb; 19(2):291-8. PubMed ID: 9498279
[TBL] [Abstract][Full Text] [Related]
13. Selective Aryl Hydrocarbon Receptor Modulator 3,3'-Diindolylmethane Impairs AhR and ARNT Signaling and Protects Mouse Neuronal Cells Against Hypoxia.
Rzemieniec J; Litwa E; Wnuk A; Lason W; Krzeptowski W; Kajta M
Mol Neurobiol; 2016 Oct; 53(8):5591-606. PubMed ID: 26476840
[TBL] [Abstract][Full Text] [Related]
14. Aryl hydrocarbon receptor activation by aminoflavone: new molecular target for renal cancer treatment.
Callero MA; Suárez GV; Luzzani G; Itkin B; Nguyen B; Loaiza-Perez AI
Int J Oncol; 2012 Jul; 41(1):125-34. PubMed ID: 22485252
[TBL] [Abstract][Full Text] [Related]
15. Distinct roles for aryl hydrocarbon receptor nuclear translocator and ah receptor in estrogen-mediated signaling in human cancer cell lines.
Labrecque MP; Takhar MK; Hollingshead BD; Prefontaine GG; Perdew GH; Beischlag TV
PLoS One; 2012; 7(1):e29545. PubMed ID: 22235307
[TBL] [Abstract][Full Text] [Related]
16. The aryl hydrocarbon receptor interacts with estrogen receptor alpha and orphan receptors COUP-TFI and ERRalpha1.
Klinge CM; Kaur K; Swanson HI
Arch Biochem Biophys; 2000 Jan; 373(1):163-74. PubMed ID: 10620335
[TBL] [Abstract][Full Text] [Related]
17. Breast cancer stem-like cells are inhibited by a non-toxic aryl hydrocarbon receptor agonist.
Prud'homme GJ; Glinka Y; Toulina A; Ace O; Subramaniam V; Jothy S
PLoS One; 2010 Nov; 5(11):e13831. PubMed ID: 21072210
[TBL] [Abstract][Full Text] [Related]
18. Aryl hydrocarbon receptor/cytochrome P450 1A1 pathway mediates breast cancer stem cells expansion through PTEN inhibition and β-Catenin and Akt activation.
Al-Dhfyan A; Alhoshani A; Korashy HM
Mol Cancer; 2017 Jan; 16(1):14. PubMed ID: 28103884
[TBL] [Abstract][Full Text] [Related]
19. Expression of the aryl hydrocarbon receptor is not required for the proliferation, migration, invasion, or estrogen-dependent tumorigenesis of MCF-7 breast cancer cells.
Spink BC; Bennett JA; Lostritto N; Cole JR; Spink DC
Mol Carcinog; 2013 Jul; 52(7):544-54. PubMed ID: 22388733
[TBL] [Abstract][Full Text] [Related]
20. A novel prenylflavone restricts breast cancer cell growth through AhR-mediated destabilization of ERα protein.
Tiong CT; Chen C; Zhang SJ; Li J; Soshilov A; Denison MS; Lee LS; Tam VH; Wong SP; Xu HE; Yong EL
Carcinogenesis; 2012 May; 33(5):1089-97. PubMed ID: 22345291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]